ResMed (RMD) Stock Price, News & Analysis

Company Overview

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 1.23 million shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 0.90%
• Price Target: N/A
• Consensus Rating: N/A

RMD Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of ResMed own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ResMed investors own include CSL (CSL), Altium (ALU), BHP Group (BHP), Credit Corp Group (CCP), Cochlear (COH), Moderna (MRNA) and Abbott Laboratories (ABT).

Company Calendar

• Ex-Dividend for 12/11 Dividend: 11/05/2024
• Dividend Payable: 12/11/2024
• Today: 12/21/2024

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: Medical Equipment
• Current Symbol: ASX:RMD
• CUSIP: N/A
• CIK: N/A
• Web: www.resmed.com
• Phone: +1-858-7462400
• Fax: N/A
• Employees: 9,980
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): A$1.00
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: 2.01
• Net Income: $1.02 billion
• Net Margins: 21.79%
• Pretax Margin: N/A
• Return on Equity: 22.70%
• Return on Assets: 12.70%

Debt

• Debt-to-Equity Ratio: 17.97
• Current Ratio: 2.59
• Quick Ratio: 1.23

Sales & Book Value

• Annual Sales: $4.69 billion
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 106.15
• Book Value: A$33.11 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,470,000,000
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 0.69